Medpace was recognized with the first-ever ACRP-Avoca CRO Quality Award today during the ACRP-Avoca Awards and Recognition Ceremony taking place at the ACRP 2018 annual meeting.
The Association of Clinical Research Professionals and The Avoca Group jointly recognized leading CROs at the event.
The following ACRP-Avoca CRO Quality Awards were announced:
- First Place – Medpace
- Second Place – PAREXEL
- Third Place – Chiltern, A Covance company
Finalists for the ACRP-Avoca Quality Awards were chosen by investigational sites through a research study conducted by The Avoca Group over an eight-week period in early 2018.
In this research, investigational sites were asked to rate CRO attributes aligned to quality outcomes. Specifically, functional attributes that support quality into design, execution, and oversight of clinical trials, as well as soft-skill areas such as communication and partnership.
“We congratulate all the finalists for having proven their ability to work effectively with investigate sites. This includes their ability to appreciate site operations, manage relationships, and provide high-quality CRA support,” says Jim Kremidas, ACRP Executive Director. “Recognition of quality partners in the clinical trial community greatly supports our mission to promote excellence in clinical research.”
“We are thrilled to collaborate with ACRP and to give investigational sites a platform to recognize organizations who provide high-quality support in the clinical research process,” says Patricia Leuchten, CEO of The Avoca Group.
“Continued collaboration between sites, sponsors, and CROs, will yield long-term, positive impact on the quality and execution of clinical trials.”